Public source

Reviewed 21 Jul 2026

Completeness Fair (31%)

Virasoft KI-67 Nuclear Analysis

Virasoft

Virasoft KI-67 Nuclear Analysis automates the identification of KI-67-positive cells, providing scoring for cancer screening in breast tissue samples.

Supported by 3 papers

General Information

Product name

Virasoft KI-67 Nuclear Analysis

Company

Modality

Histopathology

Main task

Scoring (IHC quantification)

Subspeciality

Breast pathology

Organ/Specimen source

Not specified

Disease targeted

Breast cancer

Specimen type

Not specified

Staining

IHC

Stain subtype

KI-67

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Directive (IVDD)

Class:

General IVD Devices

Not verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Not specified

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Viewer systems

Not specified

Market Presence

On market since

Not specified

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Apr 23, 2026 | Last updated: Jul 21, 2026

Virasoft KI-67 Nuclear Analysis - Virasoft